{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:28:42Z","timestamp":1778322522247,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Persistent monoarthritis in otherwise well-controlled rheumatoid arthritis presents a therapeutic challenge. Intra-articular (IA) steroids are a mainstay of treatment, though some have queried whether IA disease modifying anti-rheumatic drugs (DMARD) and biologics can be used in those who fail steroid injections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic literature review was conducted using four medical databases to identify randomized, controlled trials assessing IA therapies in RA patients. Included studies underwent Cochrane Risk of Bias 2 assessment for quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twelve studies were included, 6 of which examined intra-articular (IA) TNF inhibitors (TNFi), and 6 studies evaluating IA methotrexate. Of those evaluating IA TNFi, one study reported statistical improvement in TNFi therapy when compared with placebo. The remaining 5 studies compared IA TNFi therapy with steroid injections. IA TNFi had statistically improved symptom scores and clinical assessments comparable with IA steroid treatments.<\/jats:p>\n                <jats:p>In the 6 studies evaluating IA methotrexate, the addition of methotrexate to steroid intra-articular therapy was not found to be beneficial, and singular methotrexate injection was not superior to the control arms (saline or triamcinolone). Risk-of-bias (ROB) assessment with the Revised Cochrane ROB tool indicated that 2 of 6 TNFi studies were at some risk or high risk for bias, compared with 5 out of 6 methotrexate studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>For persistent monoarthritis in rheumatoid arthritis, IA methotrexate was not found to have clinical utility. Intra-articular TNFi therapy appears to have equal efficacy to IA steroids, though the optimal dose and frequency of injections is yet unknown.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04651-5","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T17:02:33Z","timestamp":1631725353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intra-articular therapy with methotrexate or tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic review"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3459-1534","authenticated-orcid":false,"given":"Megan M.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawad","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"10","key":"4651_CR1","first-page":"1934","volume":"33","author":"BA Fisher","year":"2006","unstructured":"Fisher BA, Keat A. Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis? J Rheumatol. 2006;33(10):1934\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"4651_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/ard.59.3.233","volume":"59","author":"T Weitoft","year":"2000","unstructured":"Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting intra-articular corticosteroids. Ann Rheum Dis. 2000;59(3):233\u20135. https:\/\/doi.org\/10.1136\/ard.59.3.233.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4651_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3121\/cmr.2007.768","volume":"5","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Jung KA. Arthroscopic synovectomy in rheumatoid arthritis of wrist. Clin Med Res. 2007;5(4):244\u201350. https:\/\/doi.org\/10.3121\/cmr.2007.768.","journal-title":"Clin Med Res"},{"issue":"1","key":"4651_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MNM.0000000000001116","volume":"41","author":"A Amini","year":"2020","unstructured":"Amini A, Yahyanezhad S, Velez E, Gholamrezanezhad A, Fotoohi M, Jafari E, et al. Prospective evaluation of phosphorus-32 radiation synovectomy in patients with severe and chronic rheumatoid arthritis unresponsive to conventional medical treatment. Nucl Med Commun. 2020;41(1):65\u201372. https:\/\/doi.org\/10.1097\/MNM.0000000000001116.","journal-title":"Nucl Med Commun"},{"issue":"jul21 1","key":"4651_CR5","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339(jul21 1):b2700. https:\/\/doi.org\/10.1136\/bmj.b2700.","journal-title":"BMJ."},{"key":"4651_CR6","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ."},{"issue":"7990","key":"4651_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0140-6736(76)91250-2","volume":"2","author":"JS Marks","year":"1976","unstructured":"Marks JS, Stewart IM, Hunter JA. Intra-articular methotrexate in rheumatoid arthritis. Lancet. 1976;2(7990):857\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(76)91250-2.","journal-title":"Lancet."},{"issue":"2","key":"4651_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1185\/03007997709110154","volume":"5","author":"HA Bird","year":"1977","unstructured":"Bird HA, Ring EF, Daniel R, Bacon PA. Comparison of intra-articular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Curr Med Res Opin. 1977;5(2):141\u20136. https:\/\/doi.org\/10.1185\/03007997709110154.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"4651_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard.37.4.351","volume":"37","author":"GH Hall","year":"1978","unstructured":"Hall GH, Jones BJ, Head AC, Jones VE. Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Ann Rheum Dis. 1978;37(4):351\u20136. https:\/\/doi.org\/10.1136\/ard.37.4.351.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4651_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/rheumatology\/37.7.770","volume":"37","author":"T Blyth","year":"1998","unstructured":"Blyth T, Stirling A, Coote J, Land D, Hunter JA. Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Br J Rheumatol. 1998;37(7):770\u20132. https:\/\/doi.org\/10.1093\/rheumatology\/37.7.770.","journal-title":"Br J Rheumatol"},{"issue":"6","key":"4651_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/rheumatology\/keh181","volume":"43","author":"N Hasso","year":"2004","unstructured":"Hasso N, Maddison PJ, Breslin A. Intra-articular methotrexate in knee synovitis. Rheumatology (Oxford). 2004;43(6):779\u201382. https:\/\/doi.org\/10.1093\/rheumatology\/keh181.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4651_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10067-017-3843-y","volume":"37","author":"MA Mortada","year":"2018","unstructured":"Mortada MA, Abdelwhab SM, Elgawish MH. Intra-articular methotrexate versus corticosteroid injections in medium-sized joints of rheumatoid arthritis patients-an intervention study. Clin Rheumatol. 2018;37(2):331\u20137. https:\/\/doi.org\/10.1007\/s10067-017-3843-y.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4651_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/03009740600844530","volume":"35","author":"H Bliddal","year":"2006","unstructured":"Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, et al. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scand J Rheumatol. 2006;35(5):341\u20135. https:\/\/doi.org\/10.1080\/03009740600844530.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"4651_CR14","first-page":"584","volume":"35","author":"M Boesen","year":"2008","unstructured":"Boesen M, Boesen L, Jensen KE, Cimmino MA, Torp-Pedersen S, Terslev L, et al. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. J Rheumatol. 2008;35(4):584\u201391.","journal-title":"J Rheumatol"},{"issue":"6","key":"4651_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3899\/jrheum.100828","volume":"38","author":"CH Roux","year":"2011","unstructured":"Roux CH, Breuil V, Valerio L, Amoretti N, Brocq O, Albert C, et al. Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study. J Rheumatol. 2011;38(6):1009\u201311. https:\/\/doi.org\/10.3899\/jrheum.100828.","journal-title":"J Rheumatol"},{"issue":"5","key":"4651_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jbspin.2015.03.002","volume":"82","author":"C Aalbers","year":"2015","unstructured":"Aalbers C, Gerlag D, Vos K, Vervoordeldonk M, Landewe R, Tak PP. Intra-articular etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. Joint Bone Spine. 2015;82(5):338\u201344. https:\/\/doi.org\/10.1016\/j.jbspin.2015.03.002.","journal-title":"Joint Bone Spine."},{"issue":"2","key":"4651_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/0394632015593220","volume":"29","author":"F Carubbi","year":"2016","unstructured":"Carubbi F, Zugaro L, Cipriani P, Conchiglia A, Gregori L, Danniballe C, et al. Safety and efficacy of intra-articular anti-tumor necrosis factor alpha agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare. Int J Immunopathol Pharmacol. 2016;29(2):252\u201366. https:\/\/doi.org\/10.1177\/0394632015593220.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4651_CR18","doi-asserted-by":"crossref","unstructured":"Salem RM, El-Deeb AE, Elsergany M, Elsaadany H, El-Khouly R. Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients. Clin Rheumatol. 2020;40(2), 557\u2013564. https:\/\/doi.org\/10.1007\/s10067-020-05235-9.","DOI":"10.1007\/s10067-020-05235-9"},{"issue":"19","key":"4651_CR19","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967\u201375. https:\/\/doi.org\/10.1001\/jama.2017.5283.","journal-title":"JAMA."},{"issue":"8","key":"4651_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/annrheumdis-2020-217363","volume":"79","author":"K Bacon","year":"2020","unstructured":"Bacon K, LaValley MP, Jafarzadeh SR, Felson D. Does cartilage loss cause pain in osteoarthritis and if so, how much? Ann Rheum Dis. 2020;79(8):1105\u201310. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217363.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4651_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/art.1780230121","volume":"23","author":"SM Wigginton","year":"1980","unstructured":"Wigginton SM, Chu BC, Weisman MH, Howell SB. Methotrexate pharmacokinetics after intraarticular injection in patients with rheumatoid arthritis. Arthritis Rheum. 1980;23(1):119\u201322. https:\/\/doi.org\/10.1002\/art.1780230121.","journal-title":"Arthritis Rheum"},{"key":"4651_CR22","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.2147\/IJN.S85369","volume":"10","author":"AL Boechat","year":"2015","unstructured":"Boechat AL, de Oliveira CP, Tarrago AM, da Costa AG, Malheiro A, Guterres SS, et al. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model. Int J Nanomedicine. 2015;10:6603\u201314. https:\/\/doi.org\/10.2147\/IJN.S85369.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"4651_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/clpt.1986.45","volume":"39","author":"H Derendorf","year":"1986","unstructured":"Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther. 1986;39(3):313\u20137. https:\/\/doi.org\/10.1038\/clpt.1986.45.","journal-title":"Clin Pharmacol Ther"},{"key":"4651_CR24","doi-asserted-by":"publisher","first-page":"117954411988630","DOI":"10.1177\/1179544119886303","volume":"12","author":"M Tada","year":"2019","unstructured":"Tada M, Inui K, Okano T, Mamoto K, Koike T, Nakamura H. Safety of intra-articular methotrexate injection with and without electroporation for inflammatory small joints in patients with rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2019;12:117954411988630. https:\/\/doi.org\/10.1177\/1179544119886303.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"6","key":"4651_CR25","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1007\/s11033-020-05481-9","volume":"47","author":"V Maksimovic","year":"2020","unstructured":"Maksimovic V, Pavlovic-Popovic Z, Vukmirovic S, Cvejic J, Mooranian A, Al-Salami H, et al. Molecular mechanism of action and pharmacokinetic properties of methotrexate. Mol Biol Rep. 2020;47(6):4699\u2013708. https:\/\/doi.org\/10.1007\/s11033-020-05481-9.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"4651_CR26","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/art.1780351009","volume":"35","author":"BW Deleuran","year":"1992","unstructured":"Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992;35(10):1170\u20138. https:\/\/doi.org\/10.1002\/art.1780351009.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4651_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1345\/aph.19126","volume":"34","author":"JM Korth-Bradley","year":"2000","unstructured":"Korth-Bradley JM, Rubin AS, Hanna RK, Simcoe DK, Lebsack ME. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother. 2000;34(2):161\u20134. https:\/\/doi.org\/10.1345\/aph.19126.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4651_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jbspin.2010.02.008","volume":"77","author":"M Haroon","year":"2010","unstructured":"Haroon M, O'Gradaigh D. Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis. Joint Bone Spine. 2010;77(3):232\u20134. https:\/\/doi.org\/10.1016\/j.jbspin.2010.02.008.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"4651_CR29","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/ard.2008.091900","volume":"67","author":"F Conti","year":"2008","unstructured":"Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Ann Rheum Dis. 2008;67(12):1787\u201390. https:\/\/doi.org\/10.1136\/ard.2008.091900.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4651_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/ard.62.8.783","volume":"62","author":"M Bokarewa","year":"2003","unstructured":"Bokarewa M, Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis. 2003;62(8):783\u20134. https:\/\/doi.org\/10.1136\/ard.62.8.783.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4651_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/keh524","volume":"44","author":"PC Taylor","year":"2005","unstructured":"Taylor PC. Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy. Rheumatology (Oxford). 2005;44(6):721\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keh524.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4651_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jbspin.2006.05.004","volume":"73","author":"H Bliddal","year":"2006","unstructured":"Bliddal H, Terslev L, Qvistgaard E, Recke P, Holm CC, Danneskiold-Samsoe B, et al. Safety of intra-articular injection of etanercept in small-joint arthritis: an uncontrolled, pilot-study with independent imaging assessment. Joint Bone Spine. 2006;73(6):714\u20137. https:\/\/doi.org\/10.1016\/j.jbspin.2006.05.004.","journal-title":"Joint Bone Spine."},{"issue":"5","key":"4651_CR33","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/art.30289","volume":"63","author":"SG Li","year":"2011","unstructured":"Li SG. Clinical image: development of miliary tuberculosis following one intraarticular injection of etanercept. Arthritis Rheum. 2011;63(5):1364. https:\/\/doi.org\/10.1002\/art.30289.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"4651_CR34","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/rheumatology\/kev325","volume":"54","author":"P Zufferey","year":"2015","unstructured":"Zufferey P, Perreau M, So A. High level of anti-drug antibodies after intra-articular injection of anti-TNF. Rheumatology (Oxford). 2015;54(12):2291\u20132. https:\/\/doi.org\/10.1093\/rheumatology\/kev325.","journal-title":"Rheumatology (Oxford)"},{"key":"4651_CR35","doi-asserted-by":"publisher","first-page":"194760352090659","DOI":"10.1177\/1947603520906597","volume":"18","author":"D Previtali","year":"2020","unstructured":"Previtali D, Merli G, Di Laura FG, Candrian C, Zaffagnini S, Filardo G. The long-lasting effects of \"placebo injections\" in knee osteoarthritis: a Meta-analysis. Cartilage. 2020;18:1947603520906597. https:\/\/doi.org\/10.1177\/1947603520906597 Epub ahead of print.","journal-title":"Cartilage."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04651-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T17:05:30Z","timestamp":1631725530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04651-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4651"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04651-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"15 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic literature review was conducted using ethical standards. Given the type of manuscript, no specific ethics approval or consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors understand BMC Musculoskeletal Disorders is an open access journal and agree to publication with the journal if accepted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to report from any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"792"}}